Pharmacogenetics and the potential for the individualization of antiretroviral therapy

Current Opinion in Infectious Diseases
Elizabeth Phillips, Simon Mallal

Abstract

Genetic associations highlighting differences in the response to HIV infection and treatment have significantly furthered our understanding of the pathogenesis, pharmacokinetics and pharmacodynamics of antiretroviral drug action and toxicities and HIV disease itself. This review focuses on the current knowledge of associations between polymorphisms and treatment outcomes in HIV with particular emphasis on clinically relevant relationships likely to lead to the individualization of antiretroviral therapy. Our understanding of the immunogenetic basis of drug toxicity has been furthered by human leucocyte antigen associations with hypersensitivities for the antiretroviral drugs abacavir and nevirapine. For abacavir in particular, the use of HLA-B*5701 as a screening test appears to be generalizable across racially diverse populations and has been supported by both observational, and blinded randomized controlled trials. Differences in HIV acquisition and progression as well as antiretroviral efficacy and toxicity will continue to provide the basis for research to define the genetic basis of such diversity. Despite the plethora of research in this area, numerous barriers exist to the successful operationalization of genetic testing...Continue Reading

References

Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·S D ZuckerK E Sherman
Apr 12, 2002·Lancet·Seth HetheringtonAllen D Roses
Oct 31, 2002·Advanced Drug Delivery Reviews·Jatinder K LambaKenneth E Thummel
Nov 6, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David W HaasRichard B Kim
Mar 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Annalise M MartinSimon Mallal
Apr 2, 2004·Nature·Wen-Hung ChungYuan-Tsong Chen
Jul 13, 2004·Pharmacogenetics·Dyfrig A HughesMunir Pirmohamed
Aug 19, 2004·AIDS·Ravi Kumar Verma, Martine Collumbien
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edwin DeJesusUNKNOWN CNA30024 Study Team
Mar 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shuen-Iu HungYuan-Tsong Chen
Apr 6, 2005·The Journal of Infectious Diseases·Philip E TarrUNKNOWN Swiss HIV Cohort Study
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonia Rodriguez-NovoaVincent Soriano
May 21, 2005·AIDS·Elizabeth J PhillipsNeil H Shear
May 21, 2005·AIDS·Cheryl A LiechtyJonathan Mermin
May 26, 2005·The Journal of Pharmacology and Experimental Therapeutics·Kelly BleasbyJohn B Pritchard
Sep 20, 2005·The Journal of Infectious Diseases·Margalida RotgerUNKNOWN Swiss HIV Cohort Study
Nov 17, 2005·Annals of Internal Medicine·David B CliffordRoy M Gulick
Jan 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heather J RibaudoUNKNOWN Adult AIDS Clinical Trials Group Study
Jan 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David NolanSimon Mallal
Apr 14, 2006·The Journal of Pharmacology and Experimental Therapeutics·Namandjé N BumpusPaul F Hollenberg
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A RauchSimon Mallal
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elizabeth J Phillips
Jun 17, 2006·Pharmaceutical Research·Grégoire DirsonRobert Farinotti
Jun 23, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Peter L AndersonCourtney V Fletcher
Jul 18, 2006·British Journal of Clinical Pharmacology·David M BurgerMark Becker
Jul 27, 2006·AIDS·Roberto LitteraPaolo Emilio Manconi
Aug 15, 2006·JAMA : the Journal of the American Medical Association·Roy M GulickUNKNOWN AIDS Clinical Trials Group (ACTG) A5095 Study Team
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marylyn D RitchieTimothy R Sterling

❮ Previous
Next ❯

Citations

Oct 17, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Allen D Roses
Sep 23, 2008·Nature Reviews. Drug Discovery·Allen D Roses
Jun 6, 2008·The New England Journal of Medicine·Linos VandekerckhoveDirk Vogelaers
Oct 2, 2008·HIV Medicine·B G GazzardUNKNOWN BHIVA Treatment Guidelines Writing Group
Feb 19, 2014·Pharmacogenomics·Marco Alessandrini, Michael S Pepper
Nov 14, 2014·Journal of the International AIDS Society·Veronika KanestriDanila Konnov
Apr 18, 2013·Drug Metabolism Reviews·Marco AlessandriniMichael Sean Pepper
Mar 3, 2009·Medicina clínica·Bernardino Roca
Oct 14, 2014·Expert Opinion on Drug Discovery·Anton Yuryev
Apr 9, 2009·Molecular Diagnosis & Therapy·Elizabeth Phillips, Simon Mallal
Jul 1, 2009·Personalized Medicine·Elizabeth J Phillips, Simon A Mallal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

European Journal of Clinical Pharmacology
Margalida Rotger, Amalio Telenti
Arthritis and Rheumatism
W O Dobbins
European Journal of Clinical Investigation
Gerhard E FeurleV Lenhard
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
C J BonhommeD Raoult
© 2021 Meta ULC. All rights reserved